论文部分内容阅读
为评价肝动脉化疗栓塞（TAE）治疗原发性肝癌的疗效，我们对1987年1月至1996年2月经本科治疗两次以上，资料较为完整的312例原发性肝癌患者进行了随访，并对本组患者的生存期及影响生存期的诸因素进行述评。一、本组资料本组312例患者，男性289例，女性23例。年龄17～73岁，平
To evaluate the efficacy of hepatic arterial chemoembolization (TAE) in the treatment of primary liver cancer, we conducted follow-up visits to 312 patients with primary liver cancer who underwent more than two years of undergraduate treatment from January 1987 to February 1996. A review was made of the patients’ survival time and the factors affecting their survival. First, the group of data in this group of 312 patients, 289 males and 23 females. Age 17 to 73 years old, flat